The serum level of midkine, a heparin-binding growth factor, as a tumor marker

Biomedical Research

Volumn 18, Issue 5, 1997, Pages 375-381

  Song, Xiao Jun ^a   Muramatsu, Hisako ^a   Aridome, Kuniaki ^b   Aikou, Takashi ^b   Koide, Norio ^c   Tsuji, Takao ^b   Muramatsu, Takashi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; MIDKINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SCREENING; CANCER SURGERY; COLON CARCINOMA; COLORECTAL CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

EID: 0030778308     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.18.375     Document Type: Article

References (30)

1. AARONSON S. A. (1991) Growth factors and cancer, Science 254, 1146-1153
2. ADACHI Y., MATSUBARA S., PEDRAZA C., OZAWA M., TSUTSUI J., TAKAMATSU H., NOGUCHI H., AKIYAMA T. and MURAMATSU T. (1996) Midkine as a novel target gene for Wilms' tumor suppressor gene (WTI). Oncogene 13, 2197-2203
3. ARIDOME K., TSUTSUI J., TAKAO S., KADOMATSU K., OZAWA M., AIKOU T. and MURAMATSU T. (1995) Increased midkine gene expression in human gastrointestinal cancers. Jap. J. Cancer Res. 86, 655-661
4. CROSS M. and DEXTER T. M. (1991) Growth factors in development, transformation, and tumorigenesis. Cell 64, 271-280
5. CZUBAYKO F., SCHULTE A. M., BERCHEM G. J. and WELLSTEIN A. (1996) Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl. Acad. Sci. USA 93, 14753-14758
6. GARVER R. I., CHAN C. S. and MILNER P. G. (1993) Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Amer. J. Respir. Cell Molec, Biol. 9, 463-466
7. GARVER R. I., RADFORD D. M., DONIS-KELLER H., WICK M. R. and MILNER P. G. (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74. 1584-1590
8. HELDIN, C.-H. and WESTERMARK B. (1989) Growth factors as transforming proteins. Eur. J. Biochem. 184, 487-496
9. KADOMATSU K., HAGIHARA M., AKHTER S., FAN Q.-W., MURAMATSU H. and MURAMATSU T. (1997) Midkine induces the transformation of NIH3T3 cells. Brit. J. Cancer 75, 354-359
10. KADOMATSU K., HUANG R.-P., SUGANUMA T., MURATA F. and MURAMATSU T. (1990) A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol. 110, 607-616
11. KADOMATSU K., TOMOMURA M. and MURAMATSU T. (1988) cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun. 151, 1312-1318
12. KANAME T., KADOMATSU K., ARIDOME K., YAMASHITA S., SAKAMOTO K., OGAWA M., MURAMATSU T. and YAMAMURA K. (1996) The expression of truncated MK in human tumors. Biochem. Biophys. Res. Commun. 219, 256-260
13. KOJIMA S., MURAMATSU H., AMANUMA H. and MURAMATSU T. (1995) Midkine enhances fibrinolytic activity of bovine endothelial cells. J. Biol. Chem. 270, 9590-9596
14. Li Y. S., MILNER P. G., CHAUHAN A. K., WATSON M. A., HOFFMAN R. M., KODNER C. M., MILBRANDT J. and DEUEL T. F. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neunte out-growth activity. Science 250, 1690-1694
15. MERENMIES J. and RAUVALA H. (1990) Molecular cloning of the 18kDa growth-associated protein of developing brain. J. Biol. Chem. 265, 16721-16724
16. MICHIKAWA M., KIKUCHI S., MURAMATSU H., MURAMATSU T. and KIM S. U. (1993) Retinoic acid responsive gene product, midkine (MK), has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J. Neurosci. Res. 35, 530-539
17. MITSIADIS T. A., SALMIVIRTA M., MURAMATSU T., MURAMATSU H., RAUVALA H., LEHTONEN E., JALKANEN M. and THESLEFF I. (1995) Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121, 37-51
18. MIYASHIRO I., KANAME T., NAKAYAMA T., NAKANORI S., YAGYU T., MONDEN T., KIKKAWA N., NISHISHO I., MURAMATSU T., MONDEN N. and AKIYAMA T. (1996) Expression of truncated midkine in human colorectal cancers. Cancer Lett. 106, 287-291
19. MIYASHIRO I., KANAME Y., SHIN E., WAKASUGI E., MONDEN T., TAKATSUKA Y., KIKKAWA N., MURAMATSU T., MONDEN M. and AKIYAMA T. (1996) Midkine expression in human breast cancers: expression of truncated form. Breast Cancer Res. Treat. 43, 1-6
20. MURAMATSU H. and MURAMATSU T. (1991) Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem. Biophys. Res. Commun. 177, 652-658
21. MURAMATSU H., SHIRAHAMA H., YONEZAWA S., MARUTA H. and MURAMATSU T. (1993) Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev. Biol. 159, 392-402
22. MURAMATSU H., SONG X., KOIDE N., HADA H., TSUJI T., KADOMATSU K., INUI T., KIMURA T., SAKAKIBARA S. and MURAMATSU T. (1996) Enzyme-linked immunoassay for midkine and its application to evalualion of midkine levels in the developing mouse brain and in sera from patients with hepatocellular carcinomas. J. Biochem. 119, 1171-1175
23. MURAMATSU T. (1993) Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int. J. Dev. Biol. 37, 183-188
24. NAKAGAWARA A., MILBRANDT J., MURAMATSU T., DEUEL T. F., ZHAO H., CNAAN A. and BRODEUR G. M. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res. 55, 1792-1797
25. O'BRIEN T., CRANSTON D., FUGGLE S., BICKNELL R. and HARRIS A. L. (1996) The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with poor outcome in patients with invasive cancers. Cancer Res. 56, 2515-2518
26. SCHULTE A. M., LAI S., KURTZ A., CZUBAYKO F., RIEGEL A. T. and WELLSTEIN A. (1996) Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc. Natl. Acad. Sci. USA 93, 14759-14764
27. TOMOMURA M., KADOMATSU K., MATSUBARA S. and MURAMATSU T. (1990) A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J. Biol. Chem. 265, 10765-10770
28. TSUTSUI J., KADOMATSU K., MATSUBARA S., NAKAGAWARA A., HAMANOUE M., TAKAO, S., SHIMAZU H., OHI Y. and MURAMATSU T. (1993) A new family of heparin-binding growth differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res. 53, 1281-1285
29. UNOKI K., OHBA N., ARIMURA H., MURAMATSU H. and MURAMATSU T. (1994) Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid responsive gene product. Invest. Opthalmol. Visual. Sci. 35, 4063-4068
30. YOSHIDA Y., GOTO M., TSUTSUI J., OZAWA M., SATO E., OSAME M. and MURAMATSU T. (1995) Midkine is present in the early stage of cerebral infarct. Dev. Brain Res. 85, 25-30